Jens‐Uwe Peters

1.8k total citations · 1 hit paper
38 papers, 1.3k citations indexed

About

Jens‐Uwe Peters is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Jens‐Uwe Peters has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 11 papers in Oncology. Recurrent topics in Jens‐Uwe Peters's work include Receptor Mechanisms and Signaling (8 papers), Computational Drug Discovery Methods (7 papers) and Diabetes Treatment and Management (7 papers). Jens‐Uwe Peters is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Computational Drug Discovery Methods (7 papers) and Diabetes Treatment and Management (7 papers). Jens‐Uwe Peters collaborates with scholars based in Switzerland, United States and France. Jens‐Uwe Peters's co-authors include Manfred Kansy, Patrizio Mattei, Patrick Schnider, Sabine Kolczewski, Will Spooren, Michael Hennig, Georg Jaeschke, Richard H. Porter, Eric Vieira and Eric Prinssen and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jens‐Uwe Peters

34 papers receiving 1.3k citations

Hit Papers

Polypharmacology – Foe or Friend? 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Polypharmacology – Foe or Friend?
    2013 357 citations Jens‐Uwe Peters Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens‐Uwe Peters Switzerland 17 737 355 349 328 204 38 1.3k
J. Kelder Netherlands 13 616 0.8× 171 0.5× 408 1.2× 286 0.9× 189 0.9× 29 1.6k
Frank E. Blaney United Kingdom 19 1.0k 1.4× 720 2.0× 296 0.8× 343 1.0× 207 1.0× 41 1.9k
Uwe Grether Switzerland 21 715 1.0× 225 0.6× 174 0.5× 343 1.0× 136 0.7× 67 1.3k
Andrew W. Stamford United States 22 604 0.8× 245 0.7× 216 0.6× 479 1.5× 92 0.5× 51 1.5k
Anna Partyka Poland 26 883 1.2× 529 1.5× 182 0.5× 539 1.6× 133 0.7× 105 1.9k
Rosa M. Soler Spain 22 913 1.2× 610 1.7× 378 1.1× 187 0.6× 74 0.4× 43 1.9k
Willie L. Whitter United States 13 1.1k 1.5× 528 1.5× 197 0.6× 1.0k 3.2× 178 0.9× 19 2.0k
Hugues‐Olivier Bertrand France 17 887 1.2× 521 1.5× 455 1.3× 209 0.6× 90 0.4× 28 1.4k
Margot W. Beukers Netherlands 27 1.0k 1.4× 418 1.2× 87 0.2× 410 1.3× 114 0.6× 42 1.9k
Nicolas Triballeau France 11 567 0.8× 176 0.5× 378 1.1× 192 0.6× 63 0.3× 13 895

Countries citing papers authored by Jens‐Uwe Peters

Since Specialization
Citations

This map shows the geographic impact of Jens‐Uwe Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens‐Uwe Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens‐Uwe Peters more than expected).

Fields of papers citing papers by Jens‐Uwe Peters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens‐Uwe Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens‐Uwe Peters. The network helps show where Jens‐Uwe Peters may publish in the future.

Co-authorship network of co-authors of Jens‐Uwe Peters

This figure shows the co-authorship network connecting the top 25 collaborators of Jens‐Uwe Peters. A scholar is included among the top collaborators of Jens‐Uwe Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens‐Uwe Peters. Jens‐Uwe Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siegrist, Romain, et al.. (2025). Discovery and In-Vivo Characterization of Kv7 Channel Openers through a Phenotypic Approach. Journal of Medicinal Chemistry. 68(16). 17412–17426.
2.
Surivet, Jean‐Philippe, Melanie Keßler, Christopher Kohl, et al.. (2025). Discovery of IDOR-1117-1680, a dual orexin receptor antagonist with fast onset and short duration of action for the treatment of insomnia. Bioorganic & Medicinal Chemistry. 122. 118132–118132.
3.
Kuhn, Bernd, et al.. (2023). Details Matter in Structure-based Drug Design. CHIMIA International Journal for Chemistry. 77(7/8). 489–489. 1 indexed citations
4.
Bendels, Stefanie, Caterina Bissantz, Grégori Gerebtzoff, et al.. (2019). Safety screening in early drug discovery: An optimized assay panel. Journal of Pharmacological and Toxicological Methods. 99. 106609–106609. 41 indexed citations
5.
Peters, Jens‐Uwe. (2012). Polypharmacology in drug discovery. Wiley eBooks. 22 indexed citations
6.
Peters, Jens‐Uwe, Henrietta Dehmlow, Uwe Grether, et al.. (2010). Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: Optimization of in vitro activity. Bioorganic & Medicinal Chemistry Letters. 20(18). 5426–5430. 11 indexed citations
7.
Peters, Jens‐Uwe, et al.. (2008). A facile Horner–Wadsworth–Emmons route to 2-quinolones. Tetrahedron Letters. 49(25). 4029–4032. 7 indexed citations
8.
Lübbers, Thomas, Luca Gobbi, Michael Hennig, et al.. (2007). 1,3-Disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(11). 2966–2970. 30 indexed citations
9.
Peters, Jens‐Uwe, Thomas Lübbers, Alexander Alanine, et al.. (2007). Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Structure–activity relationship elucidation. Bioorganic & Medicinal Chemistry Letters. 18(1). 256–261. 9 indexed citations
10.
11.
Peters, Jens‐Uwe, Thomas Lübbers, Alexander Alanine, et al.. (2007). Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Optimising brain penetration. Bioorganic & Medicinal Chemistry Letters. 18(1). 262–266. 20 indexed citations
12.
Ceccarelli, Simona, Georg Jaeschke, Bernd Buettelmann, et al.. (2006). Rational design, synthesis, and structure–activity relationship of benzoxazolones: New potent mglu5 receptor antagonists based on the fenobam structure. Bioorganic & Medicinal Chemistry Letters. 17(5). 1302–1306. 20 indexed citations
13.
Lübbers, Thomas, et al.. (2005). Short and Simple Preparation ofN-Boc-Protected Anthranilic Acidtert-Butyl Esters from 2-Bromo-Anilines. Synlett. 3107–3108. 2 indexed citations
14.
Hunziker, Daniel, Michael Hennig, & Jens‐Uwe Peters. (2005). Inhibitors of Dipeptidyl Peptidase IV - Recent Advances and Structural Views. Current Topics in Medicinal Chemistry. 5(16). 1623–1637. 28 indexed citations
15.
Porter, Richard H., Georg Jaeschke, Will Spooren, et al.. (2005). Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity. Journal of Pharmacology and Experimental Therapeutics. 315(2). 711–721. 246 indexed citations
16.
Peters, Jens‐Uwe, et al.. (2004). Aminomethylpyrimidines as novel DPP-IV inhibitors: A 105-fold activity increase by optimization of aromatic substituents. Bioorganic & Medicinal Chemistry Letters. 14(6). 1491–1493. 68 indexed citations
17.
Peters, Jens‐Uwe, Daniel Hunziker, Holger Fischer, et al.. (2004). An aminomethylpyrimidine DPP-IV inhibitor with improved properties. Bioorganic & Medicinal Chemistry Letters. 14(13). 3575–3578. 25 indexed citations
18.
Bleicher, Konrad, Matthias Nettekoven, Jens‐Uwe Peters, & R. Wyler. (2004). Lead Generation: Sowing the Seeds for Future Success. CHIMIA International Journal for Chemistry. 58(9). 588–588. 6 indexed citations
19.
20.
Peters, Jens‐Uwe, et al.. (1970). Difluorimide chemistry. Part I. Reactions of difluoroamino-alcohols. Journal of the Chemical Society C Organic. 1104–1104.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Kelder Breakdown of academic impact, for papers by Frank E. Blaney Breakdown of academic impact, for papers by Uwe Grether Breakdown of academic impact, for papers by Andrew W. Stamford Breakdown of academic impact, for papers by Anna Partyka Breakdown of academic impact, for papers by Rosa M. Soler Breakdown of academic impact, for papers by Willie L. Whitter Breakdown of academic impact, for papers by Hugues‐Olivier Bertrand Breakdown of academic impact, for papers by Margot W. Beukers Breakdown of academic impact, for papers by Nicolas Triballeau
Rankless by CCL
2026